Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Baraclude
Generic name / active ingredient
entecavir
Dosage-form class
Film-coated oral tablets (0.5 mg and 1 mg) and ready-to-use oral solution (0.05 mg/mL), as listed in the dated U.S. public label
Route
Oral
Record reviewed
2026-08-21

Copy from the pack in hand

Source-linked reading points

  • 0.5 mg and 1 mg are labelled tablet strengths; 0.05 mg/mL is the oral-solution concentration. mg, mg/mL, tablet count and millilitre amount are not the same unit and cannot be self-converted, substituted or adjusted because package numbers look similar.
  • The DailyMed 0.5 mg tablet image only corresponds to that one representative U.S. package. It cannot confirm the appearance, approval status or authenticity of another market, strength, oral solution or generic product.
  • The label warns that severe acute exacerbations can occur after anti-hepatitis B therapy is stopped. With a missed dose, a wish to stop, a product change or symptoms, take the actual package and complete medicine list to the prescribing team or pharmacist; do not decide the next step from a webpage or package image.
  • The label includes kidney-function-related product information and notes circumstances involving some post-transplant or immunosuppressive treatment that require professional assessment. Age, conditions or concomitant medicines cannot be converted by a webpage into an individual regimen; a professional must check the exact product and current label.

Reviewed presentation examples — compare every field

  • 0.5 mg per tablet; 30-tablet child-resistant bottleNDC 0003-1611-12
  • 1 mg per tablet; 30-tablet child-resistant bottleNDC 0003-1612-12
  • 0.05 mg/mL; 210 mL child-resistant bottleNDC 0003-1614-12

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-21
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image